Latam:
- As of
October 31 , Khiron reached more than 4,600 medical cannabis prescriptions filled - With more than 1,300 prescriptions filled in October, this represents greater than 130% growth over the July monthly and daily prescription rates
- Total monthly patient consultations at Khiron clinics in October far exceeded pre-pandemic levels in
February 2020 , surpassing 9,500 monthly consultations. In Q2, the Company had experienced a significant drop due to the pandemic with 4,500 patient consultations in April - Monthly patient attentions have increased significantly in the past 5 months, in part due to the Company's increased focus on telehealth, which accounts for 15% of patient consultations since launch
Latam:
- Achieved first medical cannabis sales in
Peru through 22 prescribing doctors, and with the first 4-week sales surpassing the initial monthlyColombia rate - Successfully achieved DIGEMID approval to introduce THC product to the
Peru market, with first sales anticipated in Q4,2020 - Khiron's Latam doctor education continues to grow with 210 doctors trained in
Colombia and 85 inPeru , supporting patient prescription demand - Khiron welcomes the recent
Uruguay government announcement to promote medical cannabis, an important advancement as the Company prepares for expansion intoBrazil
Financial
- Company maintains a strong cash position at the end of Q3, 2020 of CAN$14.7 million, with continued prudent expense management
- Company anticipates steady, quarter on quarter revenue growth, subject to market conditions
"We are seeing the positive impact of our highly focused sales model in the key Latam markets of
"We never lose sight of our mission to improve the quality of patients' lives, especially during this global pandemic, and so patient satisfaction is an important metric for us. We have been growing in patient prescriptions on a daily basis, despite the fact that COVID-19 cases have increased dramatically since
Webcast and Q&A
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend a webcast and Q&A to discuss the Company's corporate update.
DATE:
TIME:
PRESENTERS:
FORMAT: Live 20 minutes presentation and Q&A session
REGISTER LINK: https://event.on24.com/wcc/r/2819768/9328DB919FFBB024F2CF5F4F5119285E
About
Khiron is a vertically integrated medical and CPG cannabis company with core operations in
Leveraging its first-mover advantage and patient-oriented approach, Khiron combines global scientific expertise, product innovation, agricultural infrastructure, wholly-owned medical clinics, and online doctor education programs to drive prescription and brand loyalty to address priority medical conditions. Its Wellbeing unit launched the first branded CBD skincare brand in
Visit Khiron online at investors.khiron.ca and on Instagram @khironlife.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron's control, including the risk factors discussed in Khiron's Annual Information Form which is available on Khiron's SEDAR profile at www.sedar.com. The forward-looking information contained in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
View original content to download multimedia:http://www.prnewswire.com/news-releases/khiron-corporate-update-company-reports-increasing-latin-america-sales-activity-301164779.html
SOURCE
© Canada Newswire, source